Peninsula Wealth LLC Purchases Shares of 435 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Peninsula Wealth LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 435 shares of the medical equipment provider’s stock, valued at approximately $227,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Howard Capital Management Group LLC raised its stake in shares of Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. increased its stake in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares during the last quarter. M&T Bank Corp lifted its position in shares of Intuitive Surgical by 0.3% during the 3rd quarter. M&T Bank Corp now owns 68,581 shares of the medical equipment provider’s stock worth $33,691,000 after buying an additional 226 shares in the last quarter. World Investment Advisors LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $228,000. Finally, Arvest Bank Trust Division bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $260,000. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $493.60 on Monday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $175.81 billion, a P/E ratio of 77.00, a P/E/G ratio of 5.85 and a beta of 1.55. The firm’s 50 day simple moving average is $532.72 and its 200 day simple moving average is $532.68.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on ISRG shares. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Finally, Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.